Current through the 2024 Budget Session
Section 33-24-202 - Definitions(a) As used in this article: (i) "Code imprint" means a series of letters or numbers assigned by the manufacturer or distributor to a specific drug, or marks or monograms unique to the manufacturer or distributor of the drug, or both;(ii) "Dangerous substance" means any drug defined under W.S. 33-24-125;(iii) "Distributor" means a person who distributes for resale a drug in solid dosage form under his own label even though he is not the actual manufacturer of the drug;(iv) "Solid dosage form" means capsules or tablets intended for oral use;(v) Repealed by Laws 2019, ch. 186, § 2.Amended by Laws 2019 , ch. 186, § 2, eff. 7/1/2019.